2-[(piperidin-4-yl)methoxy]pyridine-4-carbonitrile dihydrochloride, 95.0%, 250mg

Infinitely corrected plan PL 4x/0.10 IOS objective. Working distance 11.9 mm

tert-Butyl 5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate, 96.0%, 250mg

(S,S)-(+)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II), 98%, 1g

5-Bromo-benzo[b]thiophene, 99.00%, 10g

6-Bromo-8-methyl-[1,2,4]triazolo[1,5-a]pyridine, 97%, 1g

N-Phenylhydrazinecarboxamide, 97%, 25g

4,5-Dichloro-2-(methylthio)pyrimidine, 95.0%, 10g

1-(2-Bromo-ethyl)-2-methyl-benzene, 95.0%, 1g

6-Fluoroindoline, 95.0%, 5g

4-Chloro-2-methylbenzonitrile, 98.0%, 25g

5-CYANO-2-METHYLBENZOIC ACID, 95.0%, 10g

1-(4-Fluorophenyl)-2-thiourea, 95.0%, 100g